X
MEDP icon

Xponance’s Medpace MEDP Stock Holding History

Xponance’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Sell
4,942
-24
-0.5% -$11.1K 0.02% 536
2026
Q1 		$2.38M Buy
4,966
+618
+14% +$316K 0.02% 534
2025
Q4 		$2.44M Sell
4,348
-288
-6% -$163K 0.02% 504
2025
Q3 		$2.38M Sell
4,636
-95
-2% -$41.5K 0.02% 508
2025
Q2 		$1.48M Sell
4,731
-474
-9% -$142K 0.01% 605
2025
Q1 		$1.59M Buy
5,205
+28
+0.5% +$9.42K 0.02% 575
2024
Q4 		$1.72M Buy
5,177
+171
+3% +$58K 0.02% 562
2024
Q3 		$1.67M Buy
5,006
+30
+0.6% +$11.4K 0.02% 562
2024
Q2 		$2.05M Buy
4,976
+76
+2% +$30.1K 0.02% 486
2024
Q1 		$1.98M Sell
4,900
-147
-3% -$51.7K 0.02% 523
2023
Q4 		$1.55M Sell
5,047
-213
-4% -$57.5K 0.02% 539
2023
Q3 		$1.27M Sell
5,260
-191
-4% -$48.9K 0.02% 581
2023
Q2 		$1.31M Buy
5,451
+1,415
+35% +$294K 0.02% 578
2023
Q1 		$759K Buy
4,036
+10
+0.2% +$2.07K 0.01% 754
2022
Q4 		$855K Sell
4,026
-103
-2% -$20.6K 0.01% 687
2022
Q3 		$649K Sell
4,129
-388
-9% -$61.9K 0.01% 734
2022
Q2 		$676K Buy
4,517
+33
+0.7% +$4.78K 0.01% 728
2022
Q1 		$733K Sell
4,484
-30
-0.7% -$4.95K 0.01% 718
2021
Q4 		$982K Sell
4,514
-11
-0.2% -$2.3K 0.02% 618
2021
Q3 		$856K Sell
4,525
-119
-3% -$21.7K 0.02% 632
2021
Q2 		$820K Buy
4,644
+1,395
+43% +$241K 0.02% 684
2021
Q1 		$533K Sell
3,249
-432
-12% -$66.1K 0.01% 750
2020
Q4 		$512K Buy
3,681
+25
+0.7% +$3.15K 0.01% 726
2020
Q3 		$409K Buy
+3,656
New +$423K 0.01% 730

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Xponance's MEDP Position: Q2 2026 in Review

Xponance reduced its Medpace (MEDP) stake by 0.48% in Q2 2026, selling an estimated $11.1K and leaving 4,942 shares worth $2.62M. The position accounts for 0.02% of the portfolio, ranked #536.

Xponance first reported a position in MEDP in Q3 2020 and has held it in 24 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Xponance held 4,942 shares of Medpace worth $2.62M as of Q2 2026.
  • Xponance sold 24 Medpace shares in Q2 2026, an estimated $11.1K.
  • Medpace made up 0.02% of Xponance's portfolio in Q2 2026, its #536 holding.
  • Xponance first reported a position in Medpace in Q3 2020 and has held it in 24 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.